12 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TMV | €11.60 | -0.04% | -13.9% | €1.8b | €15.43 | PE15x | E11.1% | n/a | Software | ||
FYB | €46.85 | 0.9% | -23.9% | €827.2m | €85.67 | PE12.9x | E31.5% | n/a | Pharmaceuticals & Biotech | ||
ACT | €59.60 | 3.5% | 147.3% | €606.5m | €72.05 | PE12.1x | E12.6% | 2.0% | Materials | ||
BDT | €18.05 | 7.1% | -60.2% | €182.4m | €34.25 | PE10.7x | E64.3% | 6.6% | Commercial Services | ||
DEZ | €4.01 | 0.7% | -5.3% | €557.0m | €7.16 | PE11.2x | E47.9% | 4.2% | Capital Goods | ||
IXX | €35.90 | -4.3% | 15.8% | €354.6m | €54.00 | PE19.4x | E27.8% | 1.9% | Software | ||
TTR1 | €14.20 | -2.4% | -31.4% | €98.1m | €21.00 | PE13.1x | E23.1% | 4.4% | Capital Goods | ||
PSG New | €23.40 | -4.1% | 21.9% | €280.6m | €38.75 | PE15.4x | E13.9% | 5.8% | Pharmaceuticals & Biotech | ||
A1OS | €54.00 | 1.1% | 24.7% | €263.6m | €73.00 | PE18.1x | E24.6% | 2.7% | Software | ||
2GB | €21.55 | 2.6% | -6.7% | €386.6m | €33.50 | PE21.5x | E20.5% | 0.8% | Capital Goods | ||
BFSA New | €18.50 | -2.4% | -41.5% | €740.0m | €33.32 | PE13.4x | E29.5% | 3.9% | Commercial Services | ||
KTA | €12.88 | -5.0% | -66.9% | €133.7m | €21.00 | PE7.4x | E46.5% | 22.5% | Automobiles |